Investigation of a long-term continuous glucose monitor in type 1 diabetes

Not Applicable

• Conditions: Type 1 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12617000919314
• Lead Sponsor: St Vincent's Hospital Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-06-22
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 4

Inclusion Criteria

* Type 1 diabetes mellitus for at least 5 years
* HbA1c <10%

Exclusion Criteria

* Serious chronic illness
* Use of paracetamol during the trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Investigational sensor MARD, compared with reference venous blood glucose measurements[During four in-clinic visits approximately one month apart]

Secondary Outcome Measures

Name	Time	Method
Investigational sensor MARD, compared with finger prick blood glucose measurements[At least 4x/day during at-home periods throughout the 16-week trial duration<br>];Investigational sensor MARD, compared with reference venous blood glucose measurements during different controlled physical movements and activities [Once per month];Investigational sensor MARD, compared with reference continuous glucose sensor measurements[During at-home periods throughout the 16-week trial duration]